Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive low-dose clonidine for clozapine-resistant schizophrenia
NL-OMON20882Not yet recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of clonidine in schizophrenia, schizoaffective disorder and schizophreniform disorder (3 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Change from baseline in Positive and Negative Syndrome Scale total score. Planned start Jan 2015; status: not yet recruiting.
02
Drugs
clonidine
03
Conditions
schizophreniaschizoaffective disorderschizophreniform disorder
Beyond the preview
Go deeper on NL-OMON20882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20882.